Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer
Article in Bioorganic Chemistry (March 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Cytotoxic Activity and DNA Binding Property of New Aminopyrimidine Derivatives
Article in Letters in Drug Design & Discovery (May 2020)
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Article in Frontiers in Chemistry (January 2020)